Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. - Wikidata - wikimedia - TriplyDB

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study.

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study.

http://www.wikidata.org/entity/Q51927016

about

The impact of comorbidity on cancer and its treatment Chemotherapy of ovarian cancer in elderly patients Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments Geriatric oncology: an overview of progresses and challenges.Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer.Evaluation of depression in patients with cancer in South of iran (zahedan).Safety and tolerance of radical hysterectomy for cervical cancer in the elderly Determining chemotherapy tolerance in older patients with cancer.The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).Use of geriatric assessment for older adults in the oncology setting: a systematic review.Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401 Models of Care in Geriatric Oncology.Comprehensive geriatric assessment in the older cancer patient: coming of age in clinical cancer care.Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial.Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments.Assessment and interpretation of comorbidity burden in older adults with cancer.Geriatric assessment in older patients with breast cancer.Agreement for depression diagnosis between DSM-IV-TR criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer Pilot of three objective markers of physical health and chemotherapy toxicity in older adults.The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer Doublet chemotherapy in the elderly patient with ovarian cancer.Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study Tolerance to chemotherapy in elderly patients with cancer.Senior adult oncology.Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults.Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer.Older adults and cancer treatment.Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer.The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia.Geriatric assessment in oncology practice.Assessment of health status in elderly patients with cancer.Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study.Systemic therapies for metastatic renal cell carcinoma in older adults.Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.Comprehensive geriatric assessment in 326 older women with early breast cancer.

P2860

Q26764935-93B72371-B8DF-4D16-9E95-EBC656DB8F9C Q26771397-2561137F-AE9A-48E6-985A-F3271C56E946 Q33733149-045C06A6-B183-488D-AECD-94F7AF9AF73C Q33825402-64B43A43-593D-4369-9880-9B350515AE3A Q33907387-C1630539-BF8B-4EBD-AF5A-ACE73BBBA5C8 Q33979972-07CBB762-464F-4397-A2A4-F1BFE988D9B0 Q33997290-68D955BF-5D68-4A24-831E-9CB5FD774130 Q34082333-3444ECBE-BACA-4DD8-A303-2C6C90A82930 Q34150745-84C8275E-9DB7-4484-AC0F-EBE884DDD907 Q34155010-F0909445-D303-4A6D-AEC9-D31191A9DF59 Q34276134-58058893-5489-4392-BD06-7219688026F0 Q34360763-FD49F379-E9B5-41B2-92FB-3E22E4DDB232 Q34879258-EAF1D151-196E-4F2F-AC57-40BA15788D49 Q34902002-FEA0BC62-695F-48DB-A727-2AAE4EB893C3 Q35021464-6C6FCDDF-E39B-406A-87FE-83307FB0410A Q35086832-820D3938-33B5-4668-84C3-26F2F725144C Q35214123-22F72637-D915-4CD8-A938-D7944B93062E Q35419280-C5CB398E-2795-453D-ADAB-046A5D70EB77 Q35428376-3B6159E7-CF7A-499B-8417-C002E9C5A8DD Q35862164-9F0183A9-4D73-46D6-A4B0-DFBEB8D7F546 Q36394577-8FBDEC7E-F07E-4556-A73B-D7E172D0D3DE Q36405665-E05EC345-3790-46F3-B0BB-3154DB19A52B Q36405668-809D6484-D954-476D-9472-1C4927E000F5 Q36447635-0CEA254F-8A20-4050-B54E-995455ECAD67 Q36460784-5BF6C976-3F21-4CD2-863A-0F9BF52D4021 Q36715266-37CCA454-F2FA-46FB-9DE6-8AF5AEC22529 Q36851424-BC4068AF-C4A6-40D7-998D-4095D1F0172F Q36873270-11D479C1-FF56-4BC8-9424-87F360415083 Q36879957-65042D9F-DD4F-4328-A99D-67AA4A852D5C Q36940190-B90F0638-E7CE-437A-8511-F54AB6E72C05 Q37023167-B191110D-9267-427C-A7E9-7133A377DF43 Q37140471-DFF55C25-BED7-48EC-882B-FB7BAB977354 Q37169517-E7BB7AB8-9DF9-4461-8F08-778B70370422 Q37195803-D1CC6B1B-41DE-4A49-868A-C7AF75F454C7 Q37354523-F6FBB908-F0DE-4AF1-9B12-35B674815AFC Q37392175-73CC9140-D7A5-469B-847E-23BDD5A3E045 Q37644543-0CBD2846-2D25-4BF3-8C15-465679741B51 Q37677105-20527C16-4E13-48E3-B8BD-5244B6685871 Q38207476-DEBAE016-D803-4E03-8AE0-CBB4062F11BC Q38630293-60DE69B2-A20D-4F09-AFAA-14B6E3E8DA50

P2860

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study.

http://www.wikidata.org/entity/Q51927016

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Comprehensive geriatric assess ...... ian carcinoma: a GINECO study.

@en

Comprehensive geriatric assess ...... ian carcinoma: a GINECO study.

@nl

type

label

Comprehensive geriatric assess ...... ian carcinoma: a GINECO study.

@en

Comprehensive geriatric assess ...... ian carcinoma: a GINECO study.

@nl

prefLabel

Comprehensive geriatric assess ...... ian carcinoma: a GINECO study.

@en

Comprehensive geriatric assess ...... ian carcinoma: a GINECO study.

@nl

P1433

Q51927016-7F611578-A2CD-4064-AB77-A33D5A41F938

P1476

Q51927016-56B45694-9289-4096-985C-1ECFC69D788B

P2093

Q51927016-014BDB35-59FA-4F46-85C0-CD219DA113D1

Q51927016-13D764C2-B2CA-40A0-B980-E862A3651D63

Q51927016-2C8C7165-8CA1-4241-9520-732CC0111D7C

Q51927016-3DDEB094-56A1-4984-BA22-FEEDB8564E17

Q51927016-7B0B4D1F-ADB3-496F-A0A4-E2A61D082C05

Q51927016-B8C8A7C2-6FF1-4027-B2AF-ADC2EA63B528

Q51927016-CE95B742-086A-46D2-84FD-5E86ECC0C7C8

Q51927016-F73449B9-E7C9-41F1-AAEE-CE97BA2CE03B

Q51927016-FFFBD2BA-1718-483C-8532-22054F115CC9

P2860

Q51927016-3CB7E624-26B0-4D6D-9E20-3BDB44D3DF5C

Q51927016-3FE0FCC8-1F89-4A4A-A26C-91BC7DBEDA96

Q51927016-40625F0B-8EF0-4142-BE42-F386CC4390FC

Q51927016-58675717-2419-4E34-82DC-0B4AEC1E4D01

Q51927016-8E4BDAB8-1DF0-4CD9-B7EE-D59C0C053F31

Q51927016-B21EC5DA-1444-46B4-A99A-5B5B2ECD966B

Q51927016-B58583C5-EC91-45E4-987E-5727888B5D9E

Q51927016-B6E5AEB4-8F51-4B7D-82C1-EFE993BC7B22

Q51927016-B77C8782-BD91-48E0-A0F0-0E6DF62D669D

Q51927016-BAC3D27E-53FC-43DE-BA8B-6973585A3817

P304

Q51927016-5F8B3E80-AC6E-47EC-AC51-75FF6A8BA3FD

P31

Q51927016-FB5F83DE-A755-4D4F-8AED-328FC16C718C

P356

Q51927016-9F41A855-7274-4963-AEDE-7E6941719B8C

P433

Q51927016-D4EC4C33-271C-4053-8B98-2D6BEA8ECE8B

P478

Q51927016-01A94FC1-A521-49ED-B12D-4F789EECEF4C

P50

Q51927016-E1E11D29-E0AE-423F-8B15-7BD7E4C96487

P577

Q51927016-15E9806F-0E48-4A1D-A191-044D5B8230FF

P5875

Q51927016-A824BCF7-7F88-46C2-876B-63EDBFAF6CD7

P698

Q51927016-394F94B4-FF02-4554-820B-081EA9BAC6F0

P921

Q51927016-7A5B08E9-BE65-4075-95EC-C056FD3812E5

Q51927016-EA835165-1073-470C-9227-CA795B831950

P356

P1433

Annals of Oncology

P1476

Comprehensive geriatric assess ...... ian carcinoma: a GINECO study.

@en

P2093

B Weber

http://www.w3.org/2001/XMLSchema#string

E Pujade-Lauraine

http://www.w3.org/2001/XMLSchema#string

G Freyer

http://www.w3.org/2001/XMLSchema#string

G Ganem

http://www.w3.org/2001/XMLSchema#string

J Provencal

http://www.w3.org/2001/XMLSchema#string

J-F Geay

http://www.w3.org/2001/XMLSchema#string

J-P Jacquin

http://www.w3.org/2001/XMLSchema#string

O Gisserot

http://www.w3.org/2001/XMLSchema#string

S Touzet

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

The timed "Up & Go": a test of basic functional mobility for frail elderly persons

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.

Chemotherapy of lung cancer in the elderly.

Importance of a comprehensive geriatric assessment in older cancer patients.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up.

Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience.

P304

1795-1800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDI368

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Nicole Tubiana Mathieu

P577

2005-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7667645

http://www.w3.org/2001/XMLSchema#string

P698

16093275

http://www.w3.org/2001/XMLSchema#string

P921